- Home
- RFL vs VRAR Comparison
RFL vs VRAR Comparison
Compare RFL & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- VRAR
- Stock Information
- Founded
- RFL 2017
- VRAR 2016
- Country
- RFL United States
- VRAR United States
- Employees
- RFL N/A
- VRAR N/A
- Industry
- RFL Real Estate
- VRAR Retail: Computer Software & Peripheral Equipment
- Sector
- RFL Finance
- VRAR Technology
- Exchange
- RFL Nasdaq
- VRAR Nasdaq
- Market Cap
- RFL 51.1M
- VRAR 42.4M
- IPO Year
- RFL N/A
- VRAR 2021
- Fundamental
- Price
- RFL $1.99
- VRAR $1.55
- Analyst Decision
- RFL
- VRAR Strong Buy
- Analyst Count
- RFL 0
- VRAR 1
- Target Price
- RFL N/A
- VRAR $4.67
- AVG Volume (30 Days)
- RFL 29.7K
- VRAR 316.7K
- Earning Date
- RFL 03-12-2025
- VRAR 02-13-2025
- Dividend Yield
- RFL N/A
- VRAR N/A
- EPS Growth
- RFL N/A
- VRAR N/A
- EPS
- RFL N/A
- VRAR N/A
- Revenue
- RFL $697,000.00
- VRAR $9,230,197.00
- Revenue This Year
- RFL N/A
- VRAR $39.02
- Revenue Next Year
- RFL N/A
- VRAR N/A
- P/E Ratio
- RFL N/A
- VRAR N/A
- Revenue Growth
- RFL 151.62
- VRAR N/A
- 52 Week Low
- RFL $1.29
- VRAR $0.50
- 52 Week High
- RFL $2.50
- VRAR $7.00
- Technical
- Relative Strength Index (RSI)
- RFL 47.42
- VRAR 39.84
- Support Level
- RFL $1.99
- VRAR $1.55
- Resistance Level
- RFL $2.12
- VRAR $1.73
- Average True Range (ATR)
- RFL 0.09
- VRAR 0.18
- MACD
- RFL -0.01
- VRAR -0.01
- Stochastic Oscillator
- RFL 50.00
- VRAR 10.58
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.